Skip to content

Clinical trials

Phase 4 trials in Bosnia and Herzegovina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 4 Country / region: Bosnia and Herzegovina Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20101
20111
20131
20142
20171
20191
20201
20232
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Pfizer3
Edin Mešanović2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
University Clinical Hospital Mostar1
University Medical Center, Tuzla1
University of Banja Luka1
University of Sarajevo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis1
Arthritis, Rheumatoid1
Carcinoma, Non-Small-Cell Lung1
Diabetes Mellitus, Type 21
Gastroesophageal Reflux1
Hypertension, Pulmonary1
Lymphoma, Non-Hodgkin1
Neoplasms1
Osteoarthritis1
Osteoarthritis, Knee1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.